| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/13/2007 | US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology |
| 03/13/2007 | US7189830 Anti-KSA/IL-2 fusion proteins with reduced immunogenicity |
| 03/13/2007 | US7189827 Fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides; recombinant proteins |
| 03/13/2007 | US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases |
| 03/13/2007 | US7189801 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function |
| 03/13/2007 | US7189761 Nitric oxide donor composition and method for treatment of anal disorders |
| 03/13/2007 | US7189758 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 03/13/2007 | US7189756 Pyrrolidine derivatives |
| 03/13/2007 | US7189755 Pyrrolidine melanocortin-specific compounds |
| 03/13/2007 | US7189754 Pyrrolidine ester derivatives with oxytocin modulating activity |
| 03/13/2007 | US7189751 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 03/13/2007 | US7189745 For use in therapy of diseases, in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred, cytokine antagonist, antiarthritic agent, for therapy of diabetic retinopathy |
| 03/13/2007 | US7189743 To inhibit thrombus formation |
| 03/13/2007 | US7189742 For therapy of disorder associated with elevated levels of 5-HT (5-hydroxytryptamine; serotonin) resultant from newly synthesised 5-HT, anxiety, depression, migraine and sleep apnoea |
| 03/13/2007 | US7189741 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 03/13/2007 | US7189736 Prodrugs of imidazopyridine derivatives |
| 03/13/2007 | US7189734 Anilinoquinazaolines as protein tyrosine kianse inhibitors |
| 03/13/2007 | US7189728 Inhibitors of dipeptidyl peptidase IV |
| 03/13/2007 | US7189727 Guanidino compounds |
| 03/13/2007 | US7189726 Benzofuran derivatives as inhibitors of p38-α kinase |
| 03/13/2007 | US7189720 Selective NPY (Y5) antagonists |
| 03/13/2007 | US7189719 Sodium channel blockers |
| 03/13/2007 | US7189717 Medicinal compositions promoting bowel movement |
| 03/13/2007 | US7189713 Piperidine derivatives |
| 03/13/2007 | US7189702 Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
| 03/13/2007 | US7189696 Peptide antagonists of zonulin and methods for use of the same |
| 03/13/2007 | US7189562 Mononuclear phagocytes in therapeutic drug delivery |
| 03/13/2007 | US7189390 Probiotics for pet food applications |
| 03/13/2007 | US7189389 Pharmaceutical composition of human interferon-α2 and interferon α8 subtypes |
| 03/13/2007 | US7189351 D-tagatose as an anti-biofilm agent |
| 03/13/2007 | CA2420895C Method for treating erectile dysfunction and increasing libido in men |
| 03/13/2007 | CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 03/13/2007 | CA2387533C Purine derivatives |
| 03/13/2007 | CA2381819C New benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity |
| 03/13/2007 | CA2376540C Process for preparing amlodipine benzenesulphonate |
| 03/13/2007 | CA2373128C Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
| 03/13/2007 | CA2315227C Arylpiperazines having activity at the serotonin 1a receptor |
| 03/13/2007 | CA2267224C Vitronectin receptor antagonists |
| 03/13/2007 | CA2266581C Polymers containing polysaccharides such as alginates or modified alginates |
| 03/13/2007 | CA2264063C Cryptophycin compounds |
| 03/13/2007 | CA2240494C Therapeutic molecules generated by trans-splicing |
| 03/13/2007 | CA2195053C Agents for inhibiting accumulation of visceral fat |
| 03/13/2007 | CA2116388C Treatment for viral diseases |
| 03/08/2007 | WO2007026969A1 Drug target protein and target gene, and screening method |
| 03/08/2007 | WO2007026966A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | WO2007026962A1 Phenylene derivative |
| 03/08/2007 | WO2007026928A1 Therapeutic agent for neuropathic pain |
| 03/08/2007 | WO2007026824A1 Oligonucleotide analogs |
| 03/08/2007 | WO2007026771A1 Injection for intravenous drip |
| 03/08/2007 | WO2007026761A1 Thiazole derivative |
| 03/08/2007 | WO2007026720A1 Ring-fused pyrazole derivative |
| 03/08/2007 | WO2007026664A1 Sulfonamide compound |
| 03/08/2007 | WO2007026630A1 Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid |
| 03/08/2007 | WO2007026533A1 Soluble tablet containing nanosilicon particles and process for production thereof |
| 03/08/2007 | WO2006099445A3 Nanocells for diagnosis and treatment of diseases and disorders |
| 03/08/2007 | WO2006075020A3 Ampa antagonist for the treatment of dizziness, including vertigo and meniere's disorder |
| 03/08/2007 | WO2003020702A3 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain |
| 03/08/2007 | US20070055459 Structure-based approach to design of protein-processivity factor interactions |
| 03/08/2007 | US20070054950 3-Azabicyclo[3.1.0]hexane derivatives |
| 03/08/2007 | US20070054940 Remedy for down's syndrome |
| 03/08/2007 | US20070054931 Preparation of benzoylalkyl-1,2,3,6-tetrahydropyridines and use thereof |
| 03/08/2007 | US20070054913 4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 03/08/2007 | US20070054904 Phenol derivatives and their use as rotamase inhibitors |
| 03/08/2007 | US20070054902 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists |
| 03/08/2007 | US20070054888 Novel substituted diamine derivatives useful as motilin agonists |
| 03/08/2007 | US20070054877 Antiadhesive carbohydrates |
| 03/08/2007 | US20070054876 Pharmaceutical composition promoting defecation |
| 03/08/2007 | US20070054861 Therapeutic uses of SMR1 peptides |
| 03/08/2007 | US20070054290 Bind to hedgehog polypeptides with high affinity; exhibit spatially and temporally restricted expression domains indicative of important roles in hedgehog-mediated induction |
| 03/08/2007 | US20070053929 Marine algae extract and lipase inhibitor containing the same |
| 03/08/2007 | US20070053902 Anti-alphabeta3 humanized monoclonal antibodies |
| 03/08/2007 | US20070053849 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 03/08/2007 | US20070053833 Hydrating a leukemia patient; parenterally administering a dose samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and melphalan, busulfan, and/or cyclophosphamiide; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 03/08/2007 | CA2621227A1 Thiazole derivative |
| 03/08/2007 | CA2620742A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | CA2619445A1 Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid |
| 03/07/2007 | EP1760087A1 Novel protein complex and use thereof |
| 03/07/2007 | EP1760082A1 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as anti-proliferative compounds |
| 03/07/2007 | EP1760073A1 Sulfonamide compound |
| 03/07/2007 | EP1759734A2 Aromatase inhibition to enhance assisted reproduction |
| 03/07/2007 | EP1759710A1 Remedy or preventive for arthritis |
| 03/07/2007 | EP1759701A2 Buproprion Metabolites and Methods of Their Synthesis and Use. |
| 03/07/2007 | EP1759698A1 Novel method of treatment |
| 03/07/2007 | EP1759597A2 Antiallergic composition |
| 03/07/2007 | EP1758931A1 Peptides derived from decorin leucine rich repeats and uses thereof |
| 03/07/2007 | EP1758915A2 Composition and method for inhibiting platelet aggregation |
| 03/07/2007 | EP1758614A1 Method for expressing sialylated glycoproteins in mammalian cells and cells thereof |
| 03/07/2007 | EP1758606A1 Novel use of peptide compounds for treating essential tremor and other tremor syndromes |
| 03/07/2007 | EP1758596A2 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
| 03/07/2007 | EP1758581A1 Combinations comprising a 4-isoquinolone derivative and anti-hiv agents |
| 03/07/2007 | EP1758579A1 Crth2 receptor ligands for medicinal uses |
| 03/07/2007 | EP1758571A1 Crth2 receptor ligands for therapeutic use |
| 03/07/2007 | EP1531842A4 Regulation of cell growth by muc1 |
| 03/07/2007 | EP1513842B1 Substituted hexahydropyrrolo (1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines |
| 03/07/2007 | EP1478355B1 Antitumor compositions containing taxane derivatives |
| 03/07/2007 | EP1450780B1 Use of 4-oxobutanoic acid derivatives in the treatment of inflammation |
| 03/07/2007 | EP1442025B1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 03/07/2007 | EP1427728B1 6,7-DIHYDRO-5H-PYRAZOLO 1,2-A PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY cYTOKINES |
| 03/07/2007 | EP1427411B1 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo [3.1.0] hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 03/07/2007 | EP1372651B1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity |